Category Archives: Recall

8/14 Colorado Marijuana Workshop for State and Local Public Health- Recording and Materials

https://www.colorado.gov/pacific/cdphe/marijuana-workshop-state-and-local-public-health

Elyse Contreras Retail Marijuana Program & Medical Marijuana Research Grant Program

Programs Coordinator
P 303.692.6455 | F 303.782.0904
4300 Cherry Creek Drive South, Denver, CO 80246
elyse.contreras@state.co.us
We hosted the Marijuana Workshop for State and Local Public Health on Aug. 14, 2014. 
 

Agenda

Presentations:

 

Medical Marijuana Registry – Natalie Riggins

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Natalie%20Riggins%20presentation.pdf

Medical Marijuana Research Grants Program – Ken Gershman

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Ken%20Gershman%20presentation.pdf

Retail Marijuana: Health Effects Surveillance – Tista Ghosh

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Tista%20Ghosh%20presentation.pdf

Retail Marijuana Public Helath Advisory Committee & Occupational Health and Safety Work Group – Mike Van Dyke

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Mike%20VanDyke%20presentationV2.pdf

WIC Surveillance – Jill Bonczynski, Tri-County Health Department

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Jill%20Bonczynski%20Presentation.pdf

Laboratory Contaminant Testing – Laura Gillim-Ross

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Laura%20Gillim-Ross%20presentation.pdf

Perspective of a marijuana insider handouts – Max Montrose

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Max%20Montrose%20Handout.pdf

Perspective of a marijuana insider PowerPoint presentation – Max Montrose

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Max%20Montrose%20presentation.pdf

Perspectives of a recommending physician – Joe Cohen

Office of Behavioral Health Community Prevention Programs and Statewide Efforts – Stan Paprocki, Colorado Department of Human Services

 

Public Health Prevention Services – Ali Maffey, CDPHE and Heath Harmon, Boulder County Public Health

https://www.colorado.gov/pacific/sites/default/files/CHEIS-ALI-MAFFEY-PRESENTATION.pdf

 

***Note from Anna. Please take the time to read this information.

Comments Off

Filed under Activism, Affordable Care Act, Cancer, Cannabidiol, Cannabis, CBD, Charlotte'sWeb, Child patients, Citizen abuse, Class action civil lawsuit, Colorado, Colorado Governor John Hickenlooper, Compassionate care, Compassionate use, DEA, Denver, Denver Mayor Michael Hancock, Eric Holder, Fake/altered MMj research, FBI, Fraud, General Election, Government spending, Growing, Invasion of privacy, IRS, Job creation, Jobs, Law, Legal Activist Working Group, Leon Panetta, Marijuana, Marijuana industry, Marijuana news, Medicaid, Medicaid Fraud Control Unit, Medical, Medical Marijuana, Medicare, Medicine, Mental Illness treatment, Meth epidemic, National Cannabis Industry Association, Native Tribal, Obamacare, Patient abuse, Police, Politics, PTSD, Public Citizen’s Health Research Group, Recall, Recession, RICO, Robert Gates, Taxes, Total Legalization, Tours/vacations Marijuana, Treason, U.S. Patent: 6630507 Cannabinoids as antioxidants and neuroprotectants, U.S. Treasury, Uncategorized, United States, Universal Health Coverage, Uruguay, Veteran abuse, Veterans, Voting, Weed for Votes

Reschedule DEA Medical Marijuana as Class Five

http://www.justice.gov/dea/druginfo/ds.shtml

 

“The Drug Enforcement Administration was created by President Richard Nixon through an Executive Order in July 1973 in order to establish a single unified command to combat “an all-out global war on the drug menace.” At its outset, DEA had 1,470 Special Agents and a budget of less than $75 million. Today, the DEA has nearly 5,000 Special Agents and a budget of $2.02 billion.”

http://www.justice.gov/dea/about/history.shtml

DEA Drug Schedules

Drugs, substances, and certain chemicals used to make drugs are classified into five (5) distinct categories or schedules depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential.

The abuse rate is a determinate factor in the scheduling of the drug; for example, Schedule I drugs are considered the most dangerous class of drugs with a high potential for abuse and potentially severe psychological and/or physical dependence.

As the drug schedule changes– Schedule II, Schedule III, etc., so does the abuse potential– Schedule V drugs represents the least potential for abuse. A Listing of drugs and their schedule are located at Controlled Substance Act (CSA) Scheduling or CSA Scheduling by Alphabetical Order.

These lists describes the basic or parent chemical and do not necessarily describe the salts, isomers and salts of isomers, esters, ethers and derivatives which may also be classified as controlled substances. These lists are intended as general references and are not comprehensive listings of all controlled substances.

Please note that a substance need not be listed as a controlled substance to be treated as a Schedule I substance for criminal prosecution. A controlled substance analogue is a substance which is intended for human consumption and is structurally or pharmacologically substantially similar to or is represented as being similar to a Schedule I or Schedule II substance and is not an approved medication in the United States. (See 21 U.S.C. §802(32)(A) for the definition of a controlled substance analogue and 21 U.S.C. §813 for the schedule.)

Schedule I

Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Some examples of Schedule I drugs are:

heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote

Schedule II

Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, less abuse potential than Schedule I drugs, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are:

cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin

Schedule III

Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are:

Combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), Products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone

Schedule IV

Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are:

Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien

Schedule V

Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes. Some examples of Schedule V drugs are:

cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin

 

***Note from Anna: Reclassify medical marijuana on the DEA class schedule, allow it’s use for home grows, and tax it in reasonable fashion for retail. End the black market. Impeach, recall,or fire any cop or politician on the city, state, and federal levels who doesn’t agree.

Comments Off

Filed under Activism, Affordable Care Act, Anti-corruption, Arizona, Banking laws, Banks, Bible, Big pharma, California, Cancer, Cannabidiol, Cannabis, CBD, Charlotte'sWeb, Cheap weed, Child patients, Choctaw Nation, Citizen abuse, Class action civil lawsuit, Compassionate care, Compassionate use, Corruption, Cowboy Indian Alliance, DEA, Defeat the alcohol monopoly, Department of Agriculture, Department of Revenue, Dept. of Treasury, Economy, Elder abuse, Eli Lilly, Eric Holder, FBI, Fraud, GlaxoSmithKline, Gov Jay Inslee, Government spending, Governor Jan Brewer, Governor Jerry Brown, Growing, HIV, I-502, Invasion of privacy, IRS, Job creation, Jobs, Kamala Harris, Law, Legal Activist Working Group, Leon Panetta, Lydia Schaeffer, Marijuana, Marijuana industry, Marijuana news, Medicaid, Medical, Medical Marijuana, Medicare, Medicine, Mental Illness treatment, Meth epidemic, Methamphetamines, National Cannabis Industry Association, Native Indigenous, Native Tribal, Obamacare, Occupy Seattle, Olympia, Patient abuse, Police, Politics, Poverty, Premeditated murder, President Obama, Prop 215, PTSD, Public Citizen watchdog group, Recall, Recession, RICO, Robert Gates, Sally Schaeffer, Seattle, Seattle PD, Spiritual Use, Tax havens, Taxes, Total Legalization, Treason, Treasury Secretary Jack Lew, U.S. Court of Appeals, U.S. Patent: 6630507 Cannabinoids as antioxidants and neuroprotectants, U.S. Treasury, Uncategorized, United States:, Universal Health Coverage, Uruguay, Veteran abuse, Veterans, Washington State, Washington State hospitals, Weed for Votes, WSLCB

Washington State Liquor Control Board FAQs on Taxes

http://www.liq.wa.gov/marijuana/faqs-on-taxes

What are my Marijuana Excise Tax Obligations?
Per RCW 69.50.535 and WAC 314-55-089, all licensees are required to remit to the Washington State Liquor Control Board (WSLCB) an excise tax of 25 percent on all taxable sales of marijuana, marijuana concentrates, useable marijuana, and marijuana-infused products. This tax is specific to marijuana sales and does not include transportation costs or retail sales tax amounts.

Exemptions to the above where the 25 percent excise tax is not applied:

  • Transfers from licensed producers to licensed processors when they are the same entity. For example, Producer A is also Processor A. The transfer from production to processing is not a sale because it is the same entity.
  • Processor to processor sales, regardless of entity. House Bill 2304 authorized processor to processor sales but did not include any taxation.

When can I pay my excise tax?
The reporting period closes on the last day of the calendar month. You can confirm and pay your excise tax obligation any time after that.

When is my excise tax due?
Confirmation and payment of excise taxes are due no later than the 20th day of each month for the previous month’s activity. (For example: taxes for the July reporting period are due no later than August 20th.)

How do I pay my excise tax?
WSLCB will accept cash, check, cashier’s check, or money order as payment of your excise tax obligation. Cash payments will be accepted in person by appointment only at our Olympia HQ location. Please call 360-664-1789 to schedule a payment appointment.

Can I pay at Department of Revenue?
No. The Department of Revenue will not accept payments for marijuana excise tax at this time.

What should I do if I have a discrepancy in sales data or excise tax amount due?
Contact the WSLCB Marijuana Tax Unit at marijuanataxes@lcb.wa.gov or 360-664-1789. We are here to assist you with any discrepancies or irregularities.

What happens if I do not pay my taxes by the required deadline?
Per WAC 314-55-092, a penalty of 2 percent per month will be assessed on any past due payments. Failure to make a report and/or pay the license taxes and/or penalties in the manner and dates outlined in WAC 314-55-089 will be sufficient grounds for the board to suspend or revoke a marijuana license.

http://apps.leg.wa.gov/WAC/default.aspx?cite=314-55-092

What if a marijuana licensee fails to report or pay, or reports or pays late?

(1) If a marijuana licensee does not submit its monthly reports and payment(s) to the board as required in WAC 314-55-089: The licensee is subject to penalties.
Penalties: A penalty of two percent per month will be assessed on any payments postmarked after the twentieth day of the month following the month of sale. When the twentieth day of the month falls on a Saturday, Sunday, or a legal holiday, the filing must be postmarked by the U.S. Postal Service no later than the next postal business day.
Absent a postmark, the date received at the liquor control board or authorized designee, will be used to assess the penalty of two percent per month on payments received after the twentieth day of the month following the month of sale.
(2) Failure to make a report and/or pay the license taxes and/or penalties in the manner and dates outlined in WAC 314-55-089 will be sufficient grounds for the board to suspend or revoke a marijuana license.
[Statutory Authority: RCW 69.50.342 and 69.50.345. WSR 14-10-044, § 314-55-092, filed 4/30/14, effective 5/31/14. Statutory Authority: RCW 69.50.325, 69.50.331, 69.50.342, 69.50.345. WSR 13-21-104, § 314-55-092, filed 10/21/13, effective 11/21/13.]

Can I charge the purchaser for the excise tax?
The excise tax is the obligation of the seller. Any of this tax obligation intended to be passed on to the purchaser should be included in the sale price of the product.

http://dor.wa.gov/Content/FindTaxesAndRates/marijuana/Default.aspx

Taxes due on recreational marijuana

Do you hold a producer, processor or retailer marijuana business license issued by the Liquor Control Board? If so, you will also owe taxes to the Washington State Department of Revenue.

Applicable taxes

Business and occupation (B&O) tax applies to your business’s gross receipts. You also must collect and remit to Revenue the sales tax on your retail transactions. The fact sheets at right explain your obligations.

How to file and pay your taxes

Log on to Revenue’s My Account to file your monthly returns. You must file each month. If you have no business activity to report, you still must file a “no business” return.

You can also pay your taxes through My Account.

Businesses that cannot pay electronically must apply for a waiver and, in the meantime, pay their taxes by check, money order or cash.

Mail checks to:

Washington State Department of Revenue
PO Box 47464
Olympia WA 98504-7464

Cash payments – where to pay

To make an appointment to pay your taxes in cash, choose a field office location. Appointments are necessary for tax payments of $20,000 or more.

Please schedule your appointment before the due date. We encourage early payments (before the 25th) if using cash. Penalties may apply if you don’t pay your taxes by the 25th. 

Excise taxes (25 percent) paid to Liquor Control Board

Revenue is NOT accepting tax payments for the Liquor Control Board. Excise taxes due to the Liquor Control Board must be paid to them electronically or at their office in Olympia.

http://dor.wa.gov/Content/FindTaxesAndRates/marijuana/Default.aspx

Comments Off

Filed under Activism, Big pharma, Cancer, Cannabis, Charlotte'sWeb, Citizen abuse, Class action civil lawsuit, Colorado, Compassionate care, Compassionate use, Corruption, DEA, Department of Agriculture, Department of Revenue, Dept. of Treasury, Elder abuse, Eric Holder, Farming, FBI, GMO, Gov Jay Inslee, Government spending, Growing, I-502, Invasion of privacy, IRS, Job creation, Jobs, Marijuana, Marijuana industry, Marijuana news, Medical, Medical Marijuana, National Cannabis Industry Association, Native Indigenous, Native Tribal, New legislation, Obamacare, Occupy Seattle, Patient abuse, Police, Politics, Poverty, Recall, Recession, Seattle PD, Tax havens, Taxes, United States, Veteran abuse, Veterans, Voting, Washington, Washington State

Special Notice WASHINGTON STATE DEPARTMENT OF REVENUE

http://dor.wa.gov/Docs/Pubs/SpecialNotices/2014/sn_14_SB6505.pdf

PO BOX 47478 |OLYMPIA, WASHINGTON 98504-7478 | 1-800-647-7706 |

DOR.WA.GOV

Special Notice

 WASHINGTON STATE DEPARTMENT OF REVENUE
Recreational and Medical Marijuana – Repeal and Clarification
of Excise Tax Deductions, Exemptions, and Preferential Rates
Effective June 12, 2014, recreational and medical marijuana producers, processors, retailers, and businesses that provide services to marijuana businesses are excluded from certain business and occupation (B&O) tax deductions, exemptions, and preferential rates; retail sales and use tax exemptions; and other excise tax exemptions and deductions.
In addition, sales of marijuana to consumers are not eligible for any retail sales tax or use tax exemptions. (See Senate Bill (SB)6505 [Chapter 140, Laws of 2014].)Property Tax Exemptions:
For information about property tax exemptions affected by SB 6505, please see our Property Tax Special Notice – 2014 Legislative Updates: Current
Use, Marijuana, and Designated Forest Land Legislation
Note:
For purposes of this notice the term “marijuana” is used to refer to marijuana, useable marijuana, and marijuana-infused products, including marijuana concentrates, as those terms are defined under RCW 69.50.101and Engrossed Substitute House Bill (ESHB) 2304 (Chapter 192, Laws of 2014)
.
Do Any Excise Tax Deductions, Exemptions, or Preferential Rates Apply to Marijuana Before June 12, 2014?
Before June 12, 2014, businesses producing, processing, and selling marijuana and businesses that provide services to marijuana businesses may qualify for tax deductions and exemptions discussed below, if a business otherwise meets the specific requirements of that deduction or exemption.
SB 6505 also clarified that marijuana did not qualify for certain tax deductions, exemptions, or preferential rates before June 12, 2014. This special notice will specifically state when a tax deduction, exemption, or preferential rate listed in this notice does not apply before June 12, 2014.
Quick Reference Table:
At the end of this notice is a table that lists the excise tax
deductions, exemptions, and preferential rates in this notice by RCW and states if they applied before June 12, 2014.
ISSUED JUNE 12, 2014
****Note from Anna:
Are sales of “Medical Cannabis” subject to sales tax?

 

In the state of Washington, sales of medical cannabis are retail sales. As such, the selling price is subject to retail sales tax. In addition, the seller is subject to the business and occupation (B&O) tax under the retailing classification. This is true even if it is sold by a medical cannabis dispensary.

 

Sales of medical cannabis are not eligible for the retail sales tax exemption provided for prescription drugs. RCW 82.08.0281 provides an exemption from retail sales tax for certain drugs, but only when prescribed as authorized by the laws of this state. However, cannabis is a Schedule I controlled substance and cannot be prescribed under either federal or state law in Washington.

 

Chapter 69.51A RCW addresses medical cannabis, but does not authorize the prescription of medical cannabis. This chapter specifically avoids authorization of a prescription by referring to “valid documentation”, which does not equate with a prescription as defined in RCW 82.08.0281(4)(a), or as provided in RCW 69.50.308 (Prescriptions). Chapter 69.51A provides that it is only intended to protect qualifying patients, designated providers, and physicians from liability, prosecution, or criminal guilt when cannabis is possessed, used, provided or authorized.

In addition, sales of cannabis-infused products (edibles, liquids, etc.) are not eligible for the retail sales tax exemption provided for food and food ingredients under RCW 82.08.0293 as these products are not “food or food ingredients.” Therefore retail sales tax applies on sales of cannabis-infused products.

 

See our Special Notice – Sales of Medical Cannabis Remain Subject to Sales Tax (pdf)

 

Note:
Senate Bill (SB) 6505 [Chapter 140, Laws of 2014] clarified that marijuana, useable marijuana, and marijuana infused-products, including marijuana concentrates are not drugs for purposes of the sales tax exemption under RCW 82.08.0281 for prescription drugs.

 

SB 6505 also clarified that marijuana, useable marijuana, and marijuana infused-products, including marijuana concentrates are not food or food ingredients for purposes of the sales tax exemption under RCW 82.08.0293 for food and food ingredients.

These clarifications do not change how sales of medical cannabis (marijuana) are taxed. Whether sold for recreational or medical purposes, all sales of cannabis are subject to retail sales tax. For more information on these clarifications, see our Special Notice: Recreational and Medical Marijuana – Repeal and Clarification of Excise Tax Deductions, Exemptions, and Preferential Rates.

Washington State Legislature SB 6505

Comments Off

Filed under Marijuana, Marijuana industry, Marijuana news, Medical Marijuana, Medicare, National Cannabis Industry Association, Native Indigenous, Native Tribal, New legislation, Obamacare, Occupy Seattle, Occupy Wall Street, Olympia, Patient abuse, Police, Politics, Poverty, Premeditated murder, Recall, Recession, Seattle, Seattle PD, Spiritual Use, Tax havens, Taxes, Total Legalization, Tours/vacations Marijuana, Treason, Tumwater Washington, U.S. Patent: 6630507 Cannabinoids as antioxidants and neuroprotectants, U.S. Treasury

Colorado Marijuana Tax Fifth Amendment Hearing on Friday August 22 2014

For immediate release: August 21, 2014

*Please COPY and REDISTRIBUTE*

{Denver} — There will be a preliminary injunction hearing in Denver
District Court on Friday in a lawsuit brought by marijuana civil rights
activists seeking to protect their Fifth Amendment right against
self-incrimination. Plaintiffs will argue in front of The Honorable Judge
John Madden IV that payment of marijuana taxes violates a citizen’s Fifth
Amendment right against self-incrimination, since marijuana remains illegal
under federal law.

*THE PUBLIC IS ENCOURAGED TO ATTEND THIS HEARING*

Date: Friday, August 22, 2014
Time: 9am to 12noon
Location: Denver District Court (Old Building)
1437 Bannock St.
Denver, Colorado
Courtroom #203: The Honorable Judge John Madden IV

Note: Please dress nicely and maintain quiet in the courtroom. Bring a
photo ID with, as you may have to show it to get through courthouse
security.

*BACKGROUND*
Attorney Robert J. Corry, Jr. filed the lawsuit on June 9, 2014 seeking to
permanently end Colorado’s marijuana taxes, on the grounds that payment of
the taxes forces citizens to incriminate themselves as criminals under
federal law.

The complaint was filed on behalf of an unnamed licensed medical and retail
marijuana center, the “No Over Taxation” issue committee (which campaigned
against Proposition AA, the marijuana tax issue approved by Colorado voters
in 2013) and several individuals, including Kathleen Chippi, Larisa
Bolivar, Miguel Lopez and William Chengelis.

Corry is seeking unspecified damages and a refund of all tax monies
collected by the state.

If successful, Corry’s lawsuit could be the basis for overturning ALL
regulations regarding marijuana licensing and registration in Colorado on
the same grounds.

As long as marijuana remains illegal under federal law,
states cannot require people to give any information about themselves in
order to distribute or purchase marijuana. ANY and ALL requirements to
identify oneself would result in a “real and appreciable” risk of
self-incrimination, and would require a citizen to implicate himself in
federal crimes.

As witnesses, the State of Colorado has called attorneys Brian Vicente and
Christian Sederberg, two self-proclaimed “marijuana lawyers” who helped
campaign for Amendment 64, to provide testimony to support the State’s
assertion that payment of these taxes is not incriminating.

Read more about the Fifth Amendment here:
http://en.wikipedia.org/wiki/Fifth_Amendment_to_the_United_States_Constitution

Corry cites a 1973 Colorado Supreme Court case (People vs. Duleff) that
overturned a man’s conviction for “selling marijuana without a license”
because compliance with the licensing requirement would have required that
person to violate his constitutional right against self-incrimination and
reveal a violation of federal law. Corry writes, “The Colorado Supreme
Court held specifically that the Fifth Amendment prohibits state licensing
requirements that force a person to reveal a violation of federal law.”

From the Duleff decision, Corry quotes the Colo. Sup. Ct.:
“The Fifth Amendment prohibits licensing requirements from being used as a
means of discovering past or present criminal activity which is subject to
prosecution by calling attention to the licensee and his
activities….There is no doubt that the information which Duleff would
have been required to disclose would have been useful to the investigation
of his activities, would have substantially increased the risk of
prosecution, and may well have been a direct admission of guilt under
federal law. The Fifth Amendment protects individuals from such compulsory,
incriminating disclosures and provides a complete defense to prosecution.”
– Colorado Supreme Court (1973)

Corry also cites a 1969 US Supreme Court case (Timothy Leary v. United
States) in which the highest court in the country overturned Leary’s
marijuana possession conviction and ruled that the federal Marihuana Tax
Act of 1937 was illegal, due to the fact that a person seeking a tax stamp
and complying with the law would be forced to incriminate himself, in
violation of the Fifth Amendment.

Corry writes, “Marijuana-specific taxes require plaintiffs and any other
person paying said taxes to incriminate themselves as committing multiple
violations of federal law, including but not limited to, participating in,
aiding and abetting, or conspiring to commit a ‘continuing criminal
enterprise’ and ‘money laundering.’ These illegally-collected taxes are
ultimately laundered by the State of Colorado through J.P. Morgan Chase
Bank, which also participates knowingly in the continuing criminal
enterprise.” Item 67, Corry complaint filed 6/9/14.

Corry concludes, “It is illegal for government to retain tax monies
illegally collected in violation of the constitution, so all amounts must
be returned, and all records related to previous tax payments, destroyed.”

Corry asks the Court to:
“Enter a temporary restraining order, preliminary injunction, and/or
permanent injunction ordering the Defendants, and all those acting in
concert with them, to cease and desist from enforcement of the marijuana
tax statutes, to cease and desist from any further collection, deposit, or
laundering of the marijuana taxes, for a full refund of marijuana tax
monies paid by any person or entity, and for destruction of all tax records
and identifying information after full refunds are made.”

“The state can’t have it both ways. If it’s illegal under federal law, you
cannot collect taxes on it,” says Kathleen Chippi, a plaintiff and member
of the Patient and Caregiver Rights Litigation Project. “We have another
case pending in the Colorado Supreme Court now, Coats v. Dish Network,
where Colorado Attorney General John Suthers argues that medical marijuana
patients can be fired from their jobs for using medical marijuana off-duty,
even though it is legal under state law. Suthers argues in the Coats case
that, since marijuana is still illegal under federal law, patients have no
rights.”

“Yet Suthers and Hickenlooper, as kingpins in their continuing criminal
enterprise, happily collect and spend the marijuana taxes, even though they
were collected in spite of multiple clear violations of federal law,”
Chippi concludes.

Read Boulder Weekly article on Federal Preemption issues and the Coats v.
Dish Lawsuit (5/22/14):
http://www.boulderweekly.com/article-12900-local-attorney-argues-fed-laws-donrst-apply-to-mmj.html

*FOR MORE INFORMATION*

Click here to read the complaint
No Over Taxation, et al, v. Hickenlooper, et al
http://www.cannabistherapyinstitute.com/legal/colorado/propaa.complaint.corry.pdf

People v. Duleff (Colorado Supreme Court case)
http://www.cannabistherapyinstitute.com/legal/colorado/people.v.duleff.html

US v. Leary (US Supreme Court case)
http://supreme.justia.com/cases/federal/us/395/6/

Read more about the Fifth Amendment here:
http://en.wikipedia.org/wiki/Fifth_Amendment_to_the_United_States_Constitution

Patient and Caregiver Rights Litigation Project
*DONATE ONLINE*
http://www.cannabislawsuits.com/

Denver 420 Rally
http://420rally.org/

Law Firm of Robert J. Corry, Jr.
http://www.robcorry.com/

*PRESS CONTACTS*

Contact: Robert J. Corry, Jr.: (303) 634-2244
Kathleen Chippi: 888-EAT-HEMP (888-328-4367)

Provided as a Public Service by the:
Cannabis Therapy Institute
Phone: 877-420-4205
Web: http://www.CannabisTherapyInstitute.com/
Email: info@cannabistherapyinstitute.com

 

***Note from Anna: Fight for your right to cannabis or lose it. The politicians have made it very,very clear that all marijuana cultivation is going into the full control of the Federal government, no matter what the state governors think. Dispensaries, activists, and patients had better pay 100 percent attention to this case.  Every state in America is looking at Colorado for direction with setting,or eliminating, cannabis legalization laws.

If the Colorado activists lose, patients in all of the marijuana states can expect mediocre mass-produced GMO’d, barely effective weed for the little people and high-quality organic cannabis for the rich.That is if it isn’t banned altogether due to quality control, supply and demand, or greed issues by the people in control of it’s cultivation.

If citizens refuse to participate in making sure cannabis is legal then definitely learn to grow your own, but don’t be surprised if home grows of any size are met with full police/FBI/DEA response. Rich people will not allow for the poor people to prosper financially with cannabis because it means THEY lose money and the citizens would be united to vote out ALL of the politicians who betrayed them.

Time is running out until the big money fake activists and lobbyists, hell-bent on locking up cannabis for the friends, politicians, and big businesses who pay them, betray the MMJ patients. The lobbyists and politicians will absolutely betray their constituents for Election 2016 profits. Voter abuses have happened before, and they will happen again if the citizens do not very closely monitor the actions of their politicians.

 

Comments Off

Filed under Activism, Cancer, Cannabidiol, Cannabis, Charlotte'sWeb, Child patients, Citizen abuse, Class action civil lawsuit, Colorado, Colorado Governor John Hickenlooper, Corruption, DEA, Economy, Education, Eric Holder, FBI, Fraud, Government spending, Invasion of privacy, IRS, Job creation, Jobs, Law, Marijuana, Marijuana industry, Marijuana news, New legislation, Patient abuse, Premeditated murder, Public Citizen watchdog group, Recall, Recession, Taxes, Total Legalization, Tours/vacations Marijuana, Treason, Uncategorized, United States, Veteran abuse, Veterans, Voting

CDPHE Meeting on Retail Marijuana Surveillance – Thursday 8/14/2014-Patients and Press *Not* Invited

For immediate release: Aug. 13, 2014

Cannabis Press Association
http://www.cannabispressassociation.com/

Patient and Caregiver Rights Litigation Project
http://www.cannabislawsuits.com/
888-EAT-HEMP

{Denver} — The Colorado Department of Public Health and Environment
(CDPHE) will be holding an all-day meeting on Thursday, Aug. 14, concerning
their expanding roles in “retail marijuana surveillance” and other areas.

*PHYSICAL LOCATION OF MEETING*
Courtyard Marriott Cherry Creek
Skyline Ballroom
1475 South Colorado Blvd.
Denver, CO 80222
Workshop begins at 8:30 am

The CDPHE had previously only regulated medical marijuana. Their new roles in retail marijuana involve at least 6 different departments within the CDPHE. (See page 10 of “Marijuana and CDPHE” presentation below.)

The meeting will be held at the Courtyard Marriott in Denver, but there
will also be a live webinar available (See below for details.)

According to the CDPHE, “no media” will be allowed to attend the meeting,
and the agenda shows that “no patients” have been invited to share their
views in any manner, even though the subject matter directly concerns them.

The Cannabis Press Association (CPA), working with the Patient and
Caregivers Rights Litigation Project (PCRLP), discovered the meeting, after
several patients received an email invitation asking them to register for
the meeting, which was apparently sent accidentally by the CDPHE to the
wrong email distribution list.

In the email, Elyse Contreras, Programs Coordinator for the Retail
Marijuana Program & Medical Marijuana Research Grant Program at the CDPHE,
stated that the purpose of the Aug. 14 meeting is “to update our local
partners on latest information regarding marijuana surveillance, prevention
efforts, medical research, lab regulations, infused product safety and
more!”

Contreras’ invitation stated that “no media” would be allowed to attend.

When the CDPHE discovered they had sent the email invitation to patients in
error, they immediately removed the online registration form from their
website.

The Cannabis Press Association filed a Colorado Open Records Act (CORA)
request last week, asking for the location and webinar login information
for the meeting, as well as a request for the list of invitees to the
meeting.

The CDPHE ignored the CORA requests. However, CPA was able to obtain the
information from reliable sources. (See below.)

*SURVEILLANCE OF PREGNANT WOMEN*
Many topics will be covered at the all-day meeting. A primary focus will be
how the CDPHE will be performing “surveillance” on pregnant women to
determine whether cannabis used during pregnancy is harmful to children.

According to a “Marijuana and Pregnancy” presentation on the CDPHE website,
one of the new CDPHE programs includes “Birth Registry Surveillance”, which
is defined as “surveillance to determine if marijuana could be a factor in
the development of adverse birth outcomes” and includes a “thorough review
of maternal medical records” (See page 9 of “Marijuana and Pregnancy”
presentation below.)

Kathleen Chippi of the Patient and Caregiver Rights Litigation Project sees
this as another attack on patients. “This secret meeting is just another
attack on medical marijuana patients. They want to screen all birth mothers
for cannabis? The CDPHE doesn’t test new moms for GMOs, pesticides,
fracking fluids, caffeine, sugar, or pharmaceutical chemicals, so why focus
on THC, which has been used safely by humans for over 10,000 years?
Cannabis was actually prescribed commonly to ease pregnancy and the
birthing process before it was made illegal in 1937. Natural cannabinoids
(endocannabinoids) are actually abundant in all breast milk and research
has shown that they are essential to a newborn’s development.”

See: Cannabinoids, like those found in marijuana, occur naturally in human
breast milk
http://www.naturalnews.com/036526_cannabinoids_breast_milk_THC.html#ixzz3AKr2v8PH

===================================================================

*MEETING AGENDA*
Click here for agenda for the Aug. 14, 2014 CDPHE/DOR meeting:
http://cannabispressassociation.com/docs/CDPHE.Agenda.for.State.Local.Workshop-8.14.14.pdf

NOTE: The CDPHE claims that this is not a public meeting, but have refused
to provide a list of the official invitees. If you want to attend in
person, it is recommended to arrive early to try to cajole a seat out of
your public officials.

===================================================================
*WEBINAR LOGIN INFORMATION*
From: “Contreras – CDPHE, Elyse” <elyse.contreras@state.co.us>
Date: August 13, 2014 10:51:24 AM MDT
To: undisclosed-recipients:;
Subject: 8/14 Marijuana Webinar Details
Marijuana Workshop for State and Local Public Health

Follow the directions below to join the webinar beginning at 8:30 am
Thursday, August 14th. This is an all day work shop, the agenda is
attached.

This meeting is intended to allow local public health agency
representatives the opportunity to learn more abut marijuana regulation in Colorado.  No public comment or questions will be taken as the meeting is not considered an open meeting as defined in the Colorado Open Meetings Law, Section 24-6-401 et seq. 

Questions on the topics discussed can be
sent to medical.marijuana@state.co.us.

To join the meeting:
https://cdphe.adobeconnect.com/r6e3dlu1pg2/
—————-
If you have never attended an Adobe Connect meeting before:

Test your connection:
https://cdphe.adobeconnect.com/common/help/en/support/meeting_test.htm

Get a quick overview: http://www.adobe.com/products/adobeconnect.html

Elyse Contreras
Programs Coordinator
Retail Marijuana Program & Medical Marijuana Research Grant Program
P 303.692.6455  |  F 303.782.0904
4300 Cherry Creek Drive South, Denver, CO 80246
elyse.contreras@state.co.us
===================================================================

*RELATED CDPHE PRESENTATIONS*
“Marijuana and CDPHE” presentation
http://cannabispressassociation.com/docs/CDPHE.Marijuana.and.CDPHE.Presentation.CORA4.pdf

“Marijuana and Pregnancy” presentation
http://cannabispressassociation.com/docs/CDPHE.Marijuana.Pregnancy.Presentation.pdf

===================================================================
NOTE: This information was obtained as a public service by volunteers
working with the Cannabis Press Association (CPA), working with the Patient
and Caregivers Rights Litigation Project (PCRLP). Please be generous and
make a donation today.

===================================================================

For immediate release: Aug. 13, 2014

Cannabis Press Association
http://www.cannabispressassociation.com/

Patient and Caregiver Rights Litigation Project
http://www.cannabislawsuits.com/
888-EAT-HEMP


Provided as a Public Service by the:
Cannabis Press Association
“Fighting over 77 years of lies and mis-information
with over 10,000 years of history and fact.”
Web: http://www.cannabispressassociation.com/
Email: info@cannabispressassociation.com

***Note from Anna: I wish the DEA officers went after legal (and illegal) methamphetamine,steroid, and Prozac abusers with the same intensity used for illegally profiling legal medical marijuana patients.

Colorado has sold out to big pharmaceutical companies and their petty political lobbyists. It’s disturbing to watch how easy it is for judges and cops to abuse the weakest among them while running like their asses are on fire away from violent offenders on legally-distributed methamphetamines.

Stats on Meth in Colorado:

http://www.justice.gov/archive/ndic/pubs4/4300/meth.htm

National Drug Intelligence Center
Colorado Drug Threat Assessment
May 2003

“…Methamphetamine abuse is increasingly prevalent in Colorado. The number of methamphetamine-related treatment admissions to publicly funded facilities in the state increased from 1,748 in 1997 to 2,037 in 2001, according to data from ADAD. (See Table 1 in Overview section.) Since 1999 treatment admissions for methamphetamine abuse have increased each year, while admissions for cocaine, heroin, and marijuana have declined. According to ADAD, more than 83 percent of patients treated for methamphetamine abuse in 2001 were Caucasian, 54 percent were male, and nearly 33 percent were 35 or older. Nearly 43 percent of methamphetamine abusers treated during 2001 smoked the drug, 32 percent injected it, 19 percent snorted it, and 6 percent used some other method or multiple methods of administration.”

http://www.narconon.org/drug-information/colorado-drug-addiction.html

From Narconon International:

“…Colorado is crossed by eight Interstates: I-15, I-25, I-70, I-76, I-80, I-84, I-90 and I-94. The central location and high ethnic population of Denver and its suburbs makes it a perfect distribution center for drugs coming into the U.S. across the Canadian border, or for drugs being trafficked north from the Southwest border. Fifteen Ports of Entry (POE) from Canada exist in Montana, and Interstates 15 and 90 link these POEs with Denver and Salt Lake City, both major drug distribution points.

…The most dangerous aspect of the drug scene in Colorado and its cities is that drug trafficking and use is on the increase. The biggest threat is the highly addictive and physically damaging ice methamphetamine. Recent supplies of meth have been more pure and lower cost than earlier supplies.”

From Johnny Green at the Weed Blog April 3, 2013:

http://www.theweedblog.com/marijuana-patents-us-patents-on-medical-procedures-involving-cannabinoids/

Spain Study Confirms Hemp Oil Cures Cancer
http://www.endalldisease.com/spain-st…

Federal Government Reports that Marijuana Kills Cancer Cells
http://www.nbcnews.com/id/51148243/ns…

US Patent 4837228
Cannabichromene (CBC)
http://www.google.com/patents/US4837228

US Patent 4189491
Glaucoma Treatment
http://www.google.com/patents/US4189491

US Patent 5631297
Anandamide Compounds
http://www.google.com/patents/US5631297

US Patent 6132762
Pain, inflammation and arthritis
http://www.google.com/patents/US6132762

US Patent 6410588
Cannabidiol and inflammatory diseases
http://www.google.com/patents/US6410588

US Patent 6974568
Treatment for coughs
http://www.google.com/patents/US6974568

US Patent 6630507
Inflammatory and autoimmune diseases
Strokes, Alzheimer’s and Parkinson’s
http://www.google.com/patents/US6630507

US Patent 7741365
Novel polycyclic cannabinoid analogs
http://www.google.com/patents/US7741365

US Patent 7597910
Prostate cancer and prostatitis
http://www.google.com/patents/US7597910

US Patent 7977107
Detecting traces of cannabinoids
http://www.google.com/patents/US7977107

US Patent 8071641
Diabetes and insulitis
http://www.google.com/patents/US8071641

US Patent 8242178
Cannabidiol and autoimmune hepatitis
http://www.google.com/patents/US8242178

US Patent 8034843
Nausea, vomiting and motion sickness
http://www.google.com/patents/US8034843

US Patent Application 20100292345
Cannabigerol (CBG)
http://www.google.com/patents/US20100…

US Patent Application 20080181942
Multiple sclerosis and MS relapse
http://www.google.com/patents/US20080…

US Patent Application 20090197941
Chronic Obstructive Pulmonary Disease
http://www.google.com/patents/US20090…

US Patent Application 20100204312
Treating cell proliferation and cancers
http://www.google.com/patents/US20100…

US Patent Application 20080262099
Inhibition of tumour cell migration
http://www.google.com/patents/US20080…

US Patent Application 20100222437
Gastrointestinal inflammatory and cancers
http://www.google.com/patents/US20100…

Cannabis and Cannabinoid Research Studies…

Scientific Proof Cannabinoids Kill Cancer Cells :

http://youtu.be/mFBBTnv5Xbs

http://redd.it/18qiwn
http://phoenixtears.ca
http://www.phoenixtearsfoundation.com…

Copy and paste links into address bar (one at a time) :

ncbi.nlm.nih.gov/pubmed/19638490
ncbi.nlm.nih.gov/pubmed/22776349
ncbi.nlm.nih.gov/pubmed/16682966
ncbi.nlm.nih.gov/pubmed/12648025
ncbi.nlm.nih.gov/pubmed/19914218
ncbi.nlm.nih.gov/pubmed/15026328
ncbi.nlm.nih.gov/pubmed/16893424
ncbi.nlm.nih.gov/pubmed/15361550
ncbi.nlm.nih.gov/pubmed/19889794
ncbi.nlm.nih.gov/pubmed/19015962
ncbi.nlm.nih.gov/pubmed/19608284
ncbi.nlm.nih.gov/pubmed/17237277
ncbi.nlm.nih.gov/pubmed/11586361
ncbi.nlm.nih.gov/pubmed/14692532
ncbi.nlm.nih.gov/pubmed/16571653
ncbi.nlm.nih.gov/pubmed/18286801
ncbi.nlm.nih.gov/pubmed/16250836
ncbi.nlm.nih.gov/pubmed/17934890
ncbi.nlm.nih.gov/pubmed/12052046
ncbi.nlm.nih.gov/pubmed/19189054
ncbi.nlm.nih.gov/pubmed/18354058
ncbi.nlm.nih.gov/pubmed/19047095
ncbi.nlm.nih.gov/pubmed/10913156
ncbi.nlm.nih.gov/pubmed/9653194
ncbi.nlm.nih.gov/pubmed/18088200
ncbi.nlm.nih.gov/pubmed/16909207
ncbi.nlm.nih.gov/pubmed/17342320
ncbi.nlm.nih.gov/pubmed/19059457
ncbi.nlm.nih.gov/pubmed/12723496
ncbi.nlm.nih.gov/pubmed/19442536
ncbi.nlm.nih.gov/pubmed/16728591
ncbi.nlm.nih.gov/pubmed/19539619
ncbi.nlm.nih.gov/pubmed/16500647
ncbi.nlm.nih.gov/pubmed/19189659
ncbi.nlm.nih.gov/pubmed/14617682
ncbi.nlm.nih.gov/pubmed/18938775
ncbi.nlm.nih.gov/pubmed/11106791
ncbi.nlm.nih.gov/pubmed/19394652
ncbi.nlm.nih.gov/pubmed/20336665
ncbi.nlm.nih.gov/pubmed/19442435
ncbi.nlm.nih.gov/pubmed/15451022
ncbi.nlm.nih.gov/pubmed/18197164
ncbi.nlm.nih.gov/pubmed/16835997
ncbi.nlm.nih.gov/pubmed/11903061
ncbi.nlm.nih.gov/pubmed/17675107
ncbi.nlm.nih.gov/pubmed/17202146
ncbi.nlm.nih.gov/pubmed/19425170
ncbi.nlm.nih.gov/pubmed/18454173
ncbi.nlm.nih.gov/pubmed/17065222
ncbi.nlm.nih.gov/pubmed/10700234
ncbi.nlm.nih.gov/pubmed/16787257
ncbi.nlm.nih.gov/pubmed/15958274
ncbi.nlm.nih.gov/pubmed/16139274
ncbi.nlm.nih.gov/pubmed/16624285
ncbi.nlm.nih.gov/pubmed/16616335
ncbi.nlm.nih.gov/pubmed/11269508
ncbi.nlm.nih.gov/pubmed/19690545
ncbi.nlm.nih.gov/pubmed/12511587
ncbi.nlm.nih.gov/pubmed/20307616
ncbi.nlm.nih.gov/pubmed/16818634
ncbi.nlm.nih.gov/pubmed/17952650
ncbi.nlm.nih.gov/pubmed/16818650
ncbi.nlm.nih.gov/pubmed/16596790
ncbi.nlm.nih.gov/pubmed/15638794
ncbi.nlm.nih.gov/pubmed/15275820
ncbi.nlm.nih.gov/pubmed/12133838
ncbi.nlm.nih.gov/pubmed/18339876
ncbi.nlm.nih.gov/pubmed/9771884
ncbi.nlm.nih.gov/pubmed/10570948
ncbi.nlm.nih.gov/pubmed/12182964
ncbi.nlm.nih.gov/pubmed/19229996

 

Comments Off

Filed under Activism, Affordable Care Act, Cancer, Colorado, Colorado Governor John Hickenlooper, Compassionate care, Compassionate use, Corruption, DEA, Denver, Denver Mayor Michael Hancock, Department of Revenue, Eric Holder, FBI, Government spending, Growing, Inhaled Cannabis, Invasion of privacy, Job creation, Jobs, Marijuana, Marijuana industry, Marijuana news, Native Indigenous, Native Tribal, Patient abuse, Police, Politics, Recall, Recession, Taxes, Total Legalization, Treason, Uncategorized

Oil Companies Fracking Into Drinking Water Sources, New Research Shows

Energy companies are fracking for oil and gas at far shallower depths than widely believed, sometimes through underground sources of drinking water, according to research released Tuesday by Stanford University scientists.

Though researchers cautioned their study of hydraulic fracturing, or fracking, employed at two Wyoming geological formations showed no direct evidence of water-supply contamination, their work is certain to roil the public health debate over the risks of the controversial oil and gas production process.

Fracking involves high-pressure injection of millions of gallons of water mixed with sand and chemicals to crack geological formations and tap previously unreachable oil and gas reserves. Fracking fluids contain a host of chemicals, including known carcinogens and neurotoxins.

Fears about possible water contamination and air pollution have fed resistance in communities around the country, threatening to slow the oil and gas boom made possible by fracking.

Fracking into underground drinking water sources is not prohibited by the 2005 Energy Policy Act, which exempted the practice from key provisions of the Safe Drinking Water Act. But the industry has long held that it does not hydraulically fracture into underground sources of drinking water because oil and gas deposits sit far deeper than aquifers.

The study, however, found that energy companies used acid stimulation, a production method, and hydraulic fracturing in the Wind River and Fort Union geological formations that make up the Pavillion gas field and that contain both natural gas and sources of drinking water.

“Thousands of gallons of diesel fuel and millions of gallons of fluids containing numerous inorganic and organic additives were injected directly into these two formations during hundreds of stimulation events,” concluded Dominic DiGiulio and Robert Jackson of Stanford’s School of Earth Sciences in a presentation Tuesday at the American Chemical Society conference in San Francisco.

The scientists cautioned that their research, which is ongoing and has yet to be peer-reviewed, “does not say that drinking water has been contaminated by hydraulic fracturing.”

Rather, they point out that there is no way of knowing the effects of fracking into groundwater resources because regulators have not assessed the scope and impact of the activity.

“The extent and consequences of these activities are poorly documented, hindering assessments of potential resource damage and human exposure,” DiGiulio wrote.

Underground sources of drinking water, or USDWs, are a category of aquifers under the Safe Drinking Water Act that could provide water for human consumption.

“If the water isn’t being used now, it doesn’t mean it can’t be used in the future,” said DiGiulio, a Stanford research associate who recently retired from the Environmental Protection Agency. “That was the intent of identifying underground sources of drinking water: to safeguard them.”

The EPA documented in 2004 that fracking into drinking water sources had occurred when companies extracted natural gas from coal seams. But industry officials have long denied that the current oil and gas boom has resulted in fracking into drinking water sources because the hydrocarbon deposits are located in deeper geological formations.

“Thankfully, the formations where hydraulic fracturing actually is occurring…are isolated from USDWs by multiple layers and often billions of tons of impenetrable rock,” said Steve Everley, a spokesman for Energy in Depth, an industry group.

Industry officials had not seen the Stanford research.

DiGiulio and Jackson plotted the depths of fracked wells, as well as domestic drinking water wells in the Pavillion area. They found that companies used acid stimulation and hydraulic fracturing at depths of the deepest water wells near the Pavillion gas field, at 700 to 750 feet, far shallower than fracking was previously thought to occur in the area.

“It’s true that fracking often occurs miles below the surface,” said Jackson, professor of environment and energy at Stanford. “People don’t realize, though, that it’s sometimes happening less than a thousand feet underground in sources of drinking water.”

Companies say that fracking has never contaminated drinking water. The EPA launched three investigations over the last six years into possible drinking water contamination by oil and gas activity in Dimock, Pa.; Parker County, Texas; and Pavillion, Wyo. After initially finding evidence of contamination at the three sites, the EPA shelved the investigations amid allegations by environmentalists and local residents that the regulator succumbed to political pressure.

Jackson said the Stanford study’s findings underscore the need for better monitoring of fracking at shallower depths. “You can’t test the consequences of an activity if you don’t know how common it is,” he said. “We think that any fracking within a thousand feet of the surface should be more clearly documented and face greater scrutiny.”

The Stanford study focuses on Pavillion, in part because of DiGiulio’s familiarity with the area when he served as an EPA researcher in the latter stages of the Pavillion water study. Industry and the state of Wyoming questioned the EPA’s methodology after its 2011 draft report found the presence of chemicals associated with gas production in residents’ well water. In June 2013, the EPA turned over the study to Wyoming regulators, whose work is being funded by EnCana, the company accused of polluting the water in Pavillion.

The EPA study looked at whether chemicals migrated upward from fracked geological zones into people’s well water. The Stanford research does not explore the possibility of migration, focusing instead on the injection of fracking chemicals directly into geological formations that contain groundwater.

The EPA does not keep track of whether underground sources of drinking water have been hydraulically fractured as part of oil and gas development, said Alisha Johnson, a spokeswoman. “EPA does not maintain a database of all the wells being hydraulically fractured across the country,” she said in an email.

In their presentation, DiGiulio and Jackson noted that the EPA considers the Wind River formation and the Fort Union stratum below it to be underground sources of drinking water. The conventional image of tight geological formations where fracking occurs is that they are monolithic stretches of rock. But the scientists say the geology of the two formations is mostly sandstone of varying permeability and water.

“People think these formations are impermeable, and so they wonder, ‘Why are you worrying about water?’” DiGiulio said. “But it is an extremely heterogeneous environment, with areas of low and high permeability mixed together and with many lenses conducting water.”

Follow @neelaeast for energy and environmental news.

Copyright © 2014, Los Angeles Times

***Note from Anna; Big pharma wastes combined with nuke storage wastes combined with Monsanto wastes equals a full-on disaster to the environment, keeps the citizens trapped in a toxic economy, and will create a public health hazard nightmare by Winter 2015.The U.S. budget is not stable. Obamacare is not stable. Fracking causes immune system disorders.

From By | Jan 31, 2014 at Medical Daily:

…According to a recent study published in the journal Environmental Health Perspectives, babies born near fracking sites are 30 percent more likely to have birth defects.”

http://www.medicaldaily.com/birth-defects-result-fracking-natural-gas-wells-put-fetus-risk-congenital-heart-neural-tube-problems

http://ehp.niehs.nih.gov/wp-content/uploads/122/1/ehp.1306722.pdf

Fracking is absolutely unnecessary. There is an entirely new generation of scientists emerging that can better handle the challenges associated with sustainable energy creation. They are much better suited to effectively managing multicultural global infrastructure issues than their predecessors.

 

 

Comments Off

Filed under Activism, Big oil, Big pharma, California Medical Association, Cancer, Charlotte'sWeb, Citizen abuse, Class action civil lawsuit, Compassionate care, Compassionate use, Congenital Heart Defects-CHD, ConocoPhillips, Corruption, Cowboy Indian Alliance, Department of Agriculture, Dept. Of Energy, Designer drugs, Economy, Eli Lilly, Environment, Environmental disaster, EPA, Farming, Fracking, Fraud, GlaxoSmithKline, GMO, Governor Jerry Brown, Growing, Occupy Wall Street, Politics, Premeditated murder, President Obama, Public Citizen’s Health Research Group, Public Health Hazard, Recall, Recession, Secretary of Energy, Treason, Tritium, United States, Universal Health Coverage, Voting, Wyoming

University of Arizona Drops Researcher Studying Medical Marijuana for Veterans

Brittny Mejia, The Republic | azcentral.com 11:49 a.m. MST July 2, 2014

http://www.azcentral.com/story/news/arizona/2014/07/02/ua-drops-researcher-studying-medical-marijuana-vets/11956323/

The University of Arizona has abruptly ended its support of a researcher who was leading a controversial and first-of-its kind study on medical marijuana use for veterans with post-traumatic stress disorder.

Dr. Sue Sisley, the principal investigator, had approval from the Food and Drug Administration and the U.S. Public Health Service, as well as conditional approval from the UA Institutional Review Board for the study of marijuana’s effect on PTSD. Her goal was to start the study this summer.

Late last week, university officials told her they wouldn’t renew her contract, essentially stopping the study before it started.

She said she believes that action occurred because the study became too controversial, at one point creating backlash in the Legislature.

“What they’ve done is harm the veterans by delaying this very crucial research by possibly a year or more when (veterans) really needed this research to be done,” Sisley said. “We were right on the cusp of being able to implement this research and the UofA just cut it off at the knees and hurt the veteran community in Arizona more than they’ll ever realize.”

The study, which was to include 70 veterans suffering from PTSD, would have been the first and only randomized controlled trial in the country looking at marijuana in treating post-traumatic stress disorder, Sisley said.

Sisley, who works at the UA’s Phoenix medical school, said university officials e-mailed her on Friday saying they would not renew her appointment as assistant director in the Arizona Telemedicine Program and as coordinator of special projects in research administration at the Phoenix medical school, effective Sept. 26.

On Monday afternoon, she said she also received a letter saying that her academic appointment as clinical assistant professor in the Psychiatry Department would end, meaning she can no longer perform her research at the UA.

“It’d be different if it was just one of the three positions,” she said. “But this is an across-the-board termination, so it suggests that this is a direct attack on the fact that I was at the forefront of very controversial research.”

George Humphrey, assistant vice president for public affairs for the Arizona Health Sciences Center, said in an e-mail that the university would not comment on personnel matters.

But he said that the university has policies and procedures that would allow for faculty who are departing the university to continue to pursue their research projects elsewhere.

In May, the UA signed a contract with Sisley and the Multidisciplinary Association for Psychedelic Studies, a non-profit research and educational organization, to enable Sisley to conduct the randomized controlled trial at the university. The non-profit sponsored the study, and committed to providing the funding, which would total nearly $1 million.

Sisley, who has spent five years trying to bring the medical-marijuana study to fruition, said she believes the decision not to renew her contracts resulted from her education and advocacy on the barriers to marijuana research, which include finding a home and funding for the research.

She said she plans to appeal and has reached out to the American Civil Liberties Union and other organizations.

While Sisley said her primary focus is on scientific and academic pursuits, she added that she has become politically active because of the barriers on federally regulated marijuana research.

Earlier this year, when state Sen. Kimberly Yee blocked a hearing of a bill that could have helped fund Sisley’s study, some residents launched a recall effort and the UA logo became affiliated with the effort to recall her, Sisley said.

In April, Sisley said she received a phone call from Joe Garcia, senior vice president for Health Sciences, regarding her political activism.

He instructed her to provide a letter for the UA administration team, wherein she explained she did not participate in the recall effort or link the university to it. She also stated in the e-mail that she never used university resources to participate in activism. Garcia was unavailable for comment.

Sisley said she never received a response to her e-mail.

“They can call it a non-renewal, they can say I wasn’t fired, but when you strip a faculty member of 100 percent of their salary support, it’s pretty clear what they’re doing,” she said. “I think that this is retaliation for trying to provide the public with knowledge about the barriers to marijuana research.”

The university has not received any political pressure to terminate any employees, said Chris Sigurdson, senior associate vice president of university relations. Sigurdson said the university has been supportive of medical-marijuana research and had gone to the Legislature in the past to voice that support.

Some reasons for non-renewal include funding changes and changes within a unit, according to Helena Rodrigues, director of human resources, strategy and planning at the UA.

“Any individual employee should not have an expectation of continued employment past the end of an employment-contract period,” Rodrigues said.

While the FDA approved Sisley’s study three years ago, she was awaiting a permit from the U.S. Drug Enforcement Administration, which she couldn’t receive until the UA gave her a location to house the study. The study would have measured how specific doses could treat PTSD symptoms.

Sisley said if she were forced to take her research to another university, she would have to go through a new review process, which could take another year.

State Rep. Ethan Orr, R-Tucson,who earlier this year introduced the bill in the Legislature that would help fund Sisley’s study, said the research would have been useful in understanding medical marijuana.

“I think if she does not do the study at the UofA, I hope that another university would pick her up and pick this research up because it’s very valuable to us,” Orr said. “I hope that the UofA will continue to look at this type of research as well.”

Ricardo Pereyda, a former UA student and combat veteran with PTSD, said cannabis works better for treating his symptoms than prescription medication.

But Pereyda, 32, said he believes it’s essential to conduct a study like Sisley’s to provide concrete answers to whether marijuana works in treating PTSD.

“Thousands of veterans have committed suicide in the time that this study has been delayed,” Pereyda said. “How many more are going to continue to commit suicide? This could potentially be something that could see a reduction in those numbers.”

 

****Note from Anna: How many more mentally ill people have to die to please big pharmaceutical companies? When are the citizens, whose tax dollars are used to employ and maintain the lifestyles of *all* city,state, end federal politicians, going to have their needs put first? Obama should immediately fully legalize hemp and medical marijuana for nationwide(as well as global) medical and retail purposes. 

It would give millions of citizens the freedom to grow their medicines, improve their health conditions, and become financially stable through farming. It would rebuild America’s economy.

Comments Off

Filed under Activism, Affordable Care Act, Arizona, CBD, Citizen abuse, Class action civil lawsuit, Corruption, DEA, Department of Agriculture, Department of Revenue, Designer drugs, Economy, Elder abuse, Eli Lilly, Farming, Fraud, General Election, GlaxoSmithKline, GMO, Governor Jan Brewer, Head trauma, Inhaled Cannabis, Invasion of privacy, IRS, Job creation, Jobs, Law, Legal Activist Working Group, Marijuana, Marijuana industry, Marijuana news, Medical, Medical Marijuana, Medicine, Mental Illness treatment, Meth epidemic, Methamphetamines, Native Indigenous, Native Tribal, Obamacare, Patient abuse, Police, Politics, Poverty, Premeditated murder, President Obama, PTSD, Public Citizen watchdog group, Public Health Hazard, Recall, Recession, Spiritual Use, Taxes, Total Legalization, Tours/vacations Marijuana, Treason, Treasury Secretary Jack Lew, U.S. Court of Appeals, U.S. Patent: 6630507 Cannabinoids as antioxidants and neuroprotectants, United States, Universal Health Coverage, Veteran abuse, Veterans, Voting, War, Weed for Votes

City of Fife Asserts Federal Preemption Argument in Marijuana Case, Attorney General Will Defend I-502

http://www.atg.wa.gov/pressrelease.aspx?&id=32237#.U-gdB6NiIwp

FOR IMMEDIATE RELEASE August 06, 2014 Washington State Office of the Attorney General

AGO believes city’s federal preemption argument threatens to destroy marijuana Initiative 502.

OLYMPIA — The Washington State Attorney General’s Office will vigorously defend I-502, the initiative legalizing marijuana, against an argument raised by the city of Fife.

The city claims that the state law is invalid because it conflicts with federal law.

If a court accepts that argument and it is upheld on appeal, it would mean the end of the state system for legal marijuana sales in Washington.Last week the AGO moved to intervene in cases in Fife and Wenatchee challenging those cities’ bans on marijuana businesses.

The AGO intervened to ensure a proper interpretation of I-502 and to defend against any argument that federal law preempts I-502. On July 31, Fife filed a motion for summary judgment arguing, among other things, that federal law preempts I-502.

Pierce County Superior Court Judge Vicki Hogan is expected to hear arguments in the case on August 29.

Emphasizing his commitment to make every effort to defend the will of the voters in enacting I-502, Attorney General Bob Ferguson directed Solicitor General, Noah Purcell, to present oral arguments for the state.The first question for the court will be whether I-502 overrides local zoning rules and requires local governments to allow marijuana businesses.

If the court agrees with the formal opinion issued by the AGO in January 2014 concluding that I-502 does not override local zoning requirements, the case will be resolved and Fife’s federal preemption argument will become irrelevant.

(The AGO issued the formal opinion in response to a request from the Liquor Control Board.Read more about that opinion and the opinion process, here.)

If the court disagrees with the AGO’s opinion and decides I-502 requires local governments to allow marijuana businesses, then the court must decide whether I-502 is preempted by federal law. If the court finds I-502 is preempted by federal law,and it is upheld on appeal, the marijuana legalization effort would be destroyed.

“As Attorney General, my job is to make sure the will of the people is upheld,” said Ferguson. “This case and others like it threaten the heart of Initiative 502. We want to participate in all cases like this to defend the will of the voters.”“

Attorney General Ferguson is the lawyer for the people of Washington,” said Washington State Senator Jamie Pedersen, a lawyer who supported I-502. “The voters passed I-502 and it is his job to defend it. I am grateful that Ferguson is getting involved in the Fife case to protect our voters’ decisions.”

Approved by voters in 2012, I-502 legalized the possession and sale of recreational marijuana in Washington and created a system of state licensing and regulation.The cities of Wenatchee and Fife passed local ordinances that prohibit operating marijuana businesses within their cities.

The plaintiffs in SMP Retail, LLC v. Wenatchee, Graybeard Holdings, LLC v. Fife and MMH, LLC v. Fife seek to invalidate these local ordinances so they can sell recreational marijuana.-30-

The Office of the Attorney General is the chief legal office for the state of Washington with attorneys and staff in 27 divisions across the state providing legal services to roughly 200 state agencies, boards and commissions.

Attorney General Bob Ferguson is working hard to protect consumers and seniors against fraud, keep our communities safe, protect our environment and stand up for our veterans.

Visit http://www.atg.wa.gov to learn more.

****Note from Anna: This is a golden opportunity to reshape retail and medical marijuana laws. It’s also an effort to clean house of the cops, judges, politicians, and lobbyists that handed Washington State organic  hemp and marijuana industries to big business.

Contacts: Alison Dempsey-Hall, Acting Communications Director, (206) 442-4482

Comments Off

Filed under Activism, Administrative Procedures Act, Affordable Care Act, Alcohol industry, Banking laws, Big pharma, Cancer, Cannabidiol, Cannabis, CBD, Citizen abuse, Class action civil lawsuit, Compassionate care, Compassionate use, Corruption, DEA, Defeat the alcohol monopoly, Department of Agriculture, Department of Revenue, Dept. Of Energy, Dept. of Treasury, Designer drugs, Economy, Eli Lilly, EPA, Eric Holder, FBI, Fraud, Gov Jay Inslee, Government spending, I-502, Inhaled Cannabis, Invasion of privacy, Job creation, Jobs, Land Rights, Marijuana, Marijuana industry, Marijuana news, Olympia, Recall, Recession, Taxes, Total Legalization, Tours/vacations Marijuana, Treason, United States, Washington State, Weed for Votes

FDA Eases Restrictions on Experimental Ebola Drug as CDC Warns of ‘Inevitable’ Spread to U.S.

http://rt.com/usa/179100-ebola-fda-drug-cdc-spread/

RT.com August 08, 2014

While Ebola, the deadly disease spreading through parts of West Africa, has no cure, specific treatment or vaccine, there are several experimental drugs being tested in US labs. Now the FDA has lifted its hold on one of those drugs.

The US Food and Drug Administration gave Tekmira Pharmaceuticals verbal confirmation that they modified the full clinical hold the regulatory agency had placed on the company’s experimental TKM-Ebola drug, enabling the potential use on Ebola patients, Tekmira said in a statement.

“We are pleased that the FDA has considered the risk-reward of TKM-Ebola for infected patients. We have been closely watching the Ebola virus outbreak and its consequences, and we are willing to assist with any responsible use of TKM-Ebola. The foresight shown by the FDA removes one potential roadblock to doing so,” said Dr. Mark Murray, CEO and president of Tekmira.

“This current outbreak underscores the critical need for effective therapeutic agents to treat the Ebola virus. We recognize the heightened urgency of this situation, and are carefully evaluating options for use of our investigational drug within accepted clinical and regulatory protocols.”

The company, in collaboration with infectious disease researchers from Boston University and the United States Army Medical Research Institute for Infectious Diseases, showed the drug’s ability to protect non-human primates from Ebola in preclinical trials in May 2010, Tekmira said.

A Phase I clinical trial ‒ the first step towards FDA approval ‒ began on humans in January. The agency then approved a fast-track designation for the drug in March, around the same time the Ebola outbreak began in Guinea, Liberia and Sierra Leone. It has since spread to Nigeria. According to World Health Organization figures published on Wednesday, there are over 1,700 suspected and confirmed cases of Ebola in the four countries, and 932 of those patients have died from the disease.

A different drug, ZMapp by Mapp Biopharmaceutical Inc., was used to treat two American aid workers who had contracted Ebola in Liberia. ZMapp, previously only known as “a secret serum,” has not been given the go-ahead to begin human trials yet, Forbes reported. It works by boosting the immune system to battle against Ebola. The treatment consists of antibodies from lab animals exposed to the virus.

After receiving a dose of the serum, both Nancy Writebol and Dr. Kent Brantly were transferred to Atlanta’s Emory University Hospital, near the US Centers for Disease Control and Prevention. Brantly, 33, who is an employee of the international group Samaritan’s Purse, also received a blood transfusion from a 14-year-old Ebola survivor, who had been under his care before. Both American patients appear to be improving, officials have said.

With the arrival of Ebola in the US via the two aid workers ‒ who remain in isolation in Atlanta ‒ CDC Director Tom Frieden told Congress that the disease will “inevitably” spread around the world due to global air travel, but that any outbreak in the US would not be large.

Frieden testified on the epidemic in front of the House Subcommittee on Africa, Global Health, Global Human Rights and International Organizations on Thursday. “It is certainly possible that we could have ill people in the US who develop Ebola after having been exposed elsewhere,” he said in his testimony. “But we are confident that there will not be a large Ebola outbreak in the US.”

As people who have traveled to West Africa and then return to or continue on to other destinations develop Ebola-like symptoms, such as fever and gastrointestinal distress, other nations have begun testing for the disease. On Tuesday, Great Britain announced a person in Wales was being monitored by health officials following a potential exposure to the virus.

On Monday, the US experienced its first scare. Mount Sinai Hospital in Manhattan performed tests on a male patient with high fever and gastrointestinal symptoms, the hospital said in a statement. He arrived in the emergency room Monday morning, and had previously traveled to one of the West African countries where Ebola has been reported. However, by the end of the day, officials confirmed the patient had not contracted the deadly disease.

“We are all connected and inevitably there will be travelers, American citizens and others who go from these three countries ‒ or from Lagos if it doesn’t get it under control ‒ and are here with symptoms,” Frieden said.

But that does not mean that the US will become the next battlefront against the disease, a CDC spokesman clarified after Frieden’s testimony.

“It is inevitable that people are going to show up with symptoms. It is possible that some of them are going to have Ebola,” CDC spokesman Tom Skinner said, according to AFP.

****Note from Anna: The government has just made the entire nation’s citizens research test subjects for the plague. Ebola spreads faster in people with weakened immune systems. The only substance on the planet that can make the immune system strong enough to fight it is cannabis. Obama knows this. Why hasn’t the President legalized cannabis nationwide?

Authors:

Pharmacol Res. Author manuscript; available in PMC Feb 24, 2011.
Published in final edited form as:
PMCID: PMC3044336
NIHMSID: NIHMS182272

“Cannabinoid pharmacology has made important advances in recent years after the discovery of the cannabinoid receptors. These discoveries have added to our understanding of exogenous and endogenous cannabinoid signaling along with exploring the various pathways of their biosynthesis, molecular structure, inactivation, and anatomical distribution of their receptors throughout the body. The endocannabinoid system is involved in immunoregulation and neuroprotection. In this article, we have reviewed the possible mechanisms of the regulation of the immune response by endocannabinoids which include modulation of immune response in different cell types, effect on cytokine network, induction of apoptosis in immune cells and downregulation of innate and adaptive immune response.

Studies from our laboratory have suggested that administration of endocannabinoids or use of inhibitors of enzymes that breakdown the endocannabinoids, leads to immunosuppression and recovery from immune-mediated injury to organs such as the liver. Thus, manipulation of endocannabinoids in vivo may constitute a novel treatment modality against inflammatory disorders.”

Endocannabinoids and immune regulation

Info about Ebola: Ebola Hemorrhagic Fever

Comments Off

Filed under Activism, Affordable Care Act, Africa, Banking laws, Big pharma, Cancer, Cannabidiol, Cannabis, CBD, Charlotte'sWeb, Child patients, Citizen abuse, Class action civil lawsuit, Compassionate care, Compassionate use, DEA, Department of Agriculture, Department of Revenue, Designer drugs, Economy, Education, Eli Lilly, Environmental disaster, EPA, Farming, FBI, General Election, GlaxoSmithKline, Gov Jay Inslee, Government spending, Hanford Nuke Plant, Inhaled Cannabis, Medical, Medical Marijuana, Medicine, Obamacare, Patient abuse, Pfizer, Politics, Public Health Hazard, Recall, Taxes, Total Legalization, Tours/vacations Marijuana, U.S. Treasury, Uncategorized, United States, Universal Health Coverage, University of Washington Medical, Washington, Washington State, Washington State hospitals